Sartorius Stedim Biotech opens center for bioprocess innovation in USA
New research labs and process development services to enable next generation therapeutics
New research labs and process development services to enable next generation therapeutics
Modernization and supply chain diversity drive new growth
This includes $2 billion of new investment creating more than a thousand new, high-skilled jobs
In Q2 FY25, our crop protection segment reported revenue of Rs. 159 crore, with an EBIT margin of 5%
Construction of the plant will commence in 2025 with first production expected to be in 2027
The new range incorporates a product that also contains the S-PRG filler employed in the Giomer range
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
The acquisition will strengthen the overall company’s position as leading global CRO services partner
he company will focus on production of any pharmaceutical and biotechnological products
Subscribe To Our Newsletter & Stay Updated